What's new in acne? New therapeutic approaches;Quoi de neuf dans l'acné ? Nouvelles approches thérapeutiques

Annales de Dermatologie et de Venereologie

Volumn 137, Issue SUPPL. 2, 2010, Pages

  Bettoli, V ^a   Sarno, O ^a   Zauli, S ^a   Borghi, A ^a   Minghetti, S ^a   Ricci, M ^a   Mantovani, L ^a   Toni, G ^a   Virgili, A ^a  

^a UNIVERSITY OF FERRARA   (Italy)

Author keywords

Acne; Innovation; Research; Treatment

Indexed keywords

ANTI ACNE AGENT; ANTIANDROGEN; ANTISENSE OLIGONUCLEOTIDE; DAPSONE; DOXYCYCLINE; ECTOPEPTIDASE INHIBITOR; ISOTRETINOIN; LAURIC ACID; LIPID; MICROSPHERE; NANOPARTICLE; OMIGANAN PENTAHYDROCHLORYDE; POLYPEPTIDE ANTIBIOTIC AGENT; RETINOID; UNCLASSIFIED DRUG; BENZOYL PEROXIDE; COSMETIC; CYPROTERONE ACETATE; ENZYME INHIBITOR; GRANULYSIN; LYMECYCLINE; MINOCYCLINE; VACCINE;

ACNE; DRUG TOLERABILITY; HUMAN; PHOTOTHERAPY; REVIEW; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BLUE LIGHT; CLINICAL RESEARCH; CYTOTOXICITY; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; INTENSE PULSED LIGHT; PATIENT COMPLIANCE; PHOTODYNAMIC THERAPY; PROPIONIBACTERIUM ACNES; PULSED DYE LASER; RED LIGHT; SUSTAINED RELEASE FORMULATION; TREATMENT INDICATION; VISIBLE POLYCHROMATIC LIGHT;

EID: 78650884632     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0151-9638(10)70054-5     Document Type: Article

References (27)

1. T. Fakhouri, B.A. Yentzer, and S.R. Feldman Advancement in benzoyl peroxide-based acne treatment: methods to increase both efficacy and tolerability J Drugs Dermatol 8 2009 657 661
2. J. Stecová, W. Mehnert, T. Blaschke, B. Kleuser, R. Sivaramakrishnan, and C.C. Zouboulis Ciproterone acetate loading to lipid nanoparticles for topical acne treatment: particle characterization and skin uptake Pharm Res 24 2007 991 1000
3. J.S. Weiss, D.M. Thiboutot, J. Hwa, Y. Liu, and M. Graeber Long-term safety and efficacy study of adapalene 0.3% gel J Drugs Dermatol 7 2008 24 28
4. L.H. Kircik Tretinoin microsphere gel pump 0.04% versus tazarotene cream 0.05% in the treatment of mild-to-moderate facial acne vulgaris J Drugs Dermatol 8 2009 650 654
5. L.F. Eichenfield, M. Nighland, A.B. Rossi, F. Cook-Bolden, P. Grimes, and R. Fried Phase 4 study to assess tretinoin pump for the treatment of facial acne J Drugs Dermatol 7 2008 1129 1136
6. J.J. Leyden, M. Wortzman, and E.K. Baldwin Antibiotic-resistant Propionibacterium acnes suppressed by a benzoyl peroxide cleanser 6% Cutis 82 2008 417 421
7. L. Kircik, L. Green, D. Thiboutot, E. Tanghetti, D. Wilson, and S. Dhawan Comparing a novel solubilized benzoyl peroxide gel with benzoyl peroxide/clindamycin: final data from a multicenter, investigator-blind, randomized study J Drugs Dermatol 8 2009 812 818
8. J.K. Tan Adapalene 0.1% and Benzoyl peroxide 2.5%: a novel combination for treatment of acne vulgaris Skin Therapy Lett 14 2009 4 5
9. Simonart T. Down Syndrome and Delayed Occurrence of Acne. Dermatology 2010 [in press].
10. V. Bettoli, A. Borghi, R. Rossi, M. Ferroni, F. Rigolin, and A. Virgili Antibiotic resistance of propionibacteria. Four years' experience of a large number of cases in Italy Dermatology 212 2006 206 207
11. M. Marta Guarna, R. Coulson, and E. Rubinchik Anti-inflammatory activity of cationic peptides: application to the treatment of acne vulgaris FEMS Microbiol Lett 257 2006 1 6
12. E. Rubinchik, D. Dugourd, T. Algara, C. Pasetka, and H.D. Friedland Antimicrobial and antifungal activities of a novel cationic antimicrobial peptide, omiganan, in experimental skin colonisation models Int J Antimicrob Agents 34 2009 457 461
13. J.E. McInturff, S.J. Wang, T. Machleidt, T.R. Lin, A. Oren, and C.J. Hertz Granulysin-derived peptides demonstrate antimicrobial and anti-inflammatory effects against Propionibacterium acnes J Invest Dermatol 125 2005 256 263
14. A. Thielitz, D. Reinhold, R. Vetter, U. Bank, M. Helmuth, and R. Hartig Inhibitors of dipeptidyl peptidase IV and aminopeptidase N target major pathogenetic steps in acne initiation J Invest Dermatol 127 2007 1042 1051
15. S. Fimmel, A. Saborowski, B. Térouanne, C. Sultan, and C.C. Zouboulis Inhibition of the androgen receptor by antisense oligonucleotides regulates the biological activity of androgens in SZ95 sebocytes Horm Metabol Res 39 2007 149 156
16. T. Nakatsuji, M.C. Kao, J.Y. Fang, C.C. Zouboulis, L. Zhang, and R.L. Gallo Antimicrobial property of lauric acid against P.acnes: its therapeutic potential for inflammatory acne vulgaris J Invest Dermatol 129 2009 2480 2488
17. R. Skidmore, R. Kovach, C. Walker, J. Thomas, M. Bradshaw, and J. Leyden Effects of subantimicrobial-dose doxycycline in the treatment of moderate acne Arch Dermatol 139 2003 459 464
18. A.B. Fleischer Jr., S. Dinehart, D. Stough, R.T. Plott Solodyn Phase 2 Study Group; olodyn Phase 3 Study Group Safety and efficacy of a new extended-release formulation of minocycline Cutis 78 2006 21 31 (Pubitemid 44720406)
19. A.N. Sapadin, and R. Fleischmajer Tetracyclines: nonantibiotic properties and their clinical implications J Am Acad Dermatol 54 2006 258 265 Feb
20. M. Chivot Acne flares and deteriorations during oral isotretinoin Ann Dermatol Venereol 128 2001 224 228
21. A. Borghi, L. Mantovani, S. Minghetti, A. Virgili, and V. Bettoli Acute acne flare following isotretinoin administration: potential protective role of low starting dose Dermatology 218 2009 178 180
22. A. Kaminsky Less common methods to treat acne Dermatology 206 2003 68 73
23. C.C. Riddle, S.N. Terrell, M.B. Menser, D.J. Aires, and E.S. Schweiger A review of photodynamic therapy (PDT) for the treatment of acne vulgaris J Drug Dermatol 8 2009 1010 1019
24. M. Fadel, M. Salah, N. Samy, and S.J. Mona Liposomal methylene blue hydrogel for selective photodynamic therapy of acne vulgaris J Drugs Dermatol 8 2009 983 990
25. T. Nakatsuji, Y.T. Liu, C.P. Huang, C.C. Zoubouis, R.L. Gallo, and C.M. Huang Antibodies elicited by inactivated P.acnes-based vaccines exert protective immunity and attenuate the IL-8 production in human sebocytes: relevance to therapy for acne vulgaris J Invest Dermatol 128 2008 2451 2457
26. J. Kim Acne vaccines: therapeutic option for the treatment of acne vulgaris? J Invest Dermatol 128 2008 2353 2354
27. T. Nakatsuji, Y. Shi, W. Zhu, C.P. Huang, Y.R. Chen, and D.Y. Lee Bioengineering a humanized acne microenvironment model: proteomics analysis of host responses to Propionibacterium acnes infection in vivo Proteomics 8 2008 3406 3415